Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature.

Abstract

Keywords

• -

Management of operable breast cancers when patient refuses surgery. Report of two cases and review of literature.

Öz

-

Anahtar Kelimeler

• -

References

1. Reis MAG, Harkins D, Krapcho M et al. SEER cancer sta- tistics review, 1975-2003. Bethesda,MD. National Cancer Institute, 2006.
2. Gerard Lim CC, Yahaya H. Second Report of the National Cancer Registry Cancer Incidence in Malaysia 2003. National Cancer Registry, Malaysia
3. Bouchardy C, Usel M, Verkooijen HM et ak. Changing pat- tern of age specific breast cancer incidence in the Swiss canton of Geneva. Breast Cancer Res Treat 2009;DOI 10.1007/s10549-009-0478-y
4. Rainsbury RM. A patient decline mastectomy. Br J Surg 1999;86:1491-2.
5. Estevez LG, Cuevas JM, Florian AAJ et al. Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: Efficacy and correlation with biological markers in a phase II multicenter trial. Clin Cancer Res 2003;9:686-692.
6. Hind D, Wyld L, Beverley CB, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus); Cocharne data- base Syst Rev 2006;25:CD004272.
7. Oura S, Tamaki T, Hirai I et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007;14;48-54.
8. Verkooijen HM, Fioretta GM, Rapiti E et al. Patients’ re- fusal of surgery strongly impairs breast cancer survival. Ann Surg 2005;242:276-80.

9. Hortobagyi GN, Ames FC, Buzdar AU et al. Management of stage III primary breast cancer with primary chemothera- py, surgery and radiation therapy. Cancer 1988;62:2507-16
10. Bear HD, Anderson S, Brown A et al. The effect on tu- mor response of adding sequential preoperative docetaxel to preoparative doxorubicin and cyclophos- phamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol2003;21:4165-74.
11. Smith IC, Heys SD, Hutcheon AW et al. Neoadjuvant che- motherapy in breast cancer: significantly enhanced re- sponse with docetaxel. J Clin Oncol 2002;20:1456-66.
12. Ring A, Webb A, Ashley S et al. Is surgery necessary af- ter complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 2003;21:4540-5.
13. Foudraine NA, Verhoef LC, Burghouts JT. Tamoxifen as sole therapy for primary breast cancer in the elderly pa- tient. Eur J Cancer 1992;28:900-3.
14. Hind D, Wild L, Reed MW. Surgery with or without tamoxifen versus tamoxifen alone for older women with operable breast cancer: Cocharne Review. Br J Cancer 2007;96:1025-9.
15. Dubois JB, Salomon A, Gary-Bobo J, Gary-Bobo J, Pourquier H, Pujal H. Exclusive radical radiation therapy in breast carcinoma. Radiother Oncol 1991;20:24-9.